Anticoagulation Reversal for ICH

June 24, 2019 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 11, 2019 00:21:11
Episode Cover

The PrePARE Trial - Do IVFs Prevent Peri-Intubation CV Collapse?

Up to 25% of critically ill patients who undergo RSI and endotracheal intubation (ETI) may suffer cardiovascular collapse.? Many clinicians administer IVFs during RSI...

Listen

Episode 0

September 27, 2021 00:25:40
Episode Cover

Milrinone or Dobutamine for Cardiogenic Shock?

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data...

Listen

Episode 0

May 15, 2019 00:29:21
Episode Cover

Refractory Vasodilatory Shock

Emergency medicine, critical care, and acute care providers evaluate, resuscitate, and manage patients with shock on a daily basis.  Despite initial efforts, a select...

Listen